Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Pfizer |
---|---|
Information provided by: | Pfizer |
ClinicalTrials.gov Identifier: | NCT00150228 |
The purpose of the study was to measure the safety and efficacy of a 12-week flexible dosing strategy of CP-526,555 compared with placebo for smoking cessation. Post-treatment follow-up of smoking status to one year from randomization was performed in a non-treatment extension Protocol A3051019
Condition | Intervention | Phase |
---|---|---|
Smoking Cessation |
Drug: CP-526,555 (varenicline) |
Phase II |
Study Type: | Interventional |
Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
Official Title: | A Twelve-Week Double-Blind, Placebo-Controlled, Randomized, Multicenter Study Evaluating the Safety and Efficacy of a Flexible-Dosing Strategy for CP-526,555 ( 0.5 mg to 2.0 mg Total Daily Dose ) in Smoking Cessation |
Estimated Enrollment: | 300 |
Study Start Date: | December 2001 |
Study Completion Date: | September 2002 |
Ages Eligible for Study: | 18 Years to 65 Years |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
United States, Kentucky | |
Pfizer Investigational Site | |
LEXINGTON, Kentucky, United States | |
United States, Minnesota | |
Pfizer Investigational Site | |
Albert Lea, Minnesota, United States | |
Pfizer Investigational Site | |
Rochester, Minnesota, United States | |
United States, Pennsylvania | |
Pfizer Investigational Site | |
Philadelphia, Pennsylvania, United States | |
Pfizer Investigational Site | |
PHILADELPHIA, Pennsylvania, United States | |
United States, Rhode Island | |
Pfizer Investigational Site | |
PROVIDENCE, Rhode Island, United States | |
United States, Wisconsin | |
Pfizer Investigational Site | |
La Crosse, Wisconsin, United States | |
Pfizer Investigational Site | |
MADISON, Wisconsin, United States |
Study Director: | Pfizer CT.gov Call Center | Pfizer |
Study ID Numbers: | A3051016 |
Study First Received: | September 6, 2005 |
Last Updated: | May 31, 2007 |
ClinicalTrials.gov Identifier: | NCT00150228 History of Changes |
Health Authority: | United States: Food and Drug Administration |
Smoking Varenicline |
Habits Smoking |